Barrow Hanley Mewhinney & Strauss LLC Liva Nova PLC Transaction History
Barrow Hanley Mewhinney & Strauss LLC
- $28 Billion
- Q1 2024
A detailed history of Barrow Hanley Mewhinney & Strauss LLC transactions in Liva Nova PLC stock. As of the latest transaction made, Barrow Hanley Mewhinney & Strauss LLC holds 2,359,958 shares of LIVN stock, worth $129 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
2,359,958
Previous 2,372,027
0.51%
Holding current value
$129 Million
Previous $123 Million
7.57%
% of portfolio
0.47%
Previous 0.45%
Shares
16 transactions
Others Institutions Holding LIVN
# of Institutions
252Shares Held
56.2MCall Options Held
367KPut Options Held
597K-
Black Rock Inc. New York, NY7.35MShares$403 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA5.94MShares$325 Million0.25% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.28MShares$125 Million0.06% of portfolio
-
State Street Corp Boston, MA2MShares$110 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$100 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.94B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...